Health Behavior Change During COVID-19 Pandemic
2021年8月8日 更新者：University of Social Sciences and Humanities, Warsaw
Health Behavior Change During COVID-19 Pandemic: the Focus on Handwashing
This study aims at investigating handwashing behavior during COVID-19 pandemic.
It was hypothesized that social-cognitive and emotional predictors as well as COVID-19 morbidity and mortality rates within the country would be associated with handwashing behavior in the general population of adults in 14 countries.
研究概览
地位
地位
完全的
干预/治疗
干预/治疗
详细说明
This observational study aims at testing the adherence to handwashing guidelines (the World Health Organization, WHO, 2020) at two measurement points, spanning 1 month.
Adults from the general population in 14 countries (Poland, Australia, Canada, China, France, Gambia, Germany, Israel, Italy, Malaysia, Portugal, Romania, Singapore, Switzerland) will provide self-report data on handwashing behavior and its social-cognitive predictors (perceived effectiveness of handwashing, risk perception, outcome expectancy, self-efficacy, intention, planning, and action control), anxiety, as well as COVID-19 morbidity and mortality rates within the country.
研究类型
研究类型
观察性的
注册 (实际的)
注册
6079
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
-
Beijing、中国
- Peking University
-
-
-
-
-
Ramat Gan、以色列
- Bar-Ilan University
-
-
-
-
-
Fajara、冈比亚
- London School of Hygiene and Tropical Medicine (in collaboration with MRC Unit The Gambia at LSHTM)
-
-
-
-
-
Fredericton、加拿大
- University of New Brunswick
-
-
-
-
-
Berlin、德国
- Freie Universität Berlin
-
-
-
-
-
Padova、意大利
- University of Padova
-
-
-
-
-
Singapore、新加坡
- Nanyang Technological University
-
-
-
-
-
Bordeaux、法国
- University of Bordeaux
-
-
-
-
Lower Silezia
-
Wroclaw、Lower Silezia、波兰、53-328
- SWPS University of Social Sciences and Humanities
-
-
-
-
-
Melbourne、澳大利亚
- The University of Melbourne
-
-
-
-
-
Zürich、瑞士
- University of Zurich
-
-
-
-
-
Cluj-Napoca、罗马尼亚
- Babes-Bolyai Unversity
-
-
-
-
-
Lisbon、葡萄牙
- University of Lisbon
-
-
-
-
-
Serdang、马来西亚
- Perdana University
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
是的
有资格学习的性别
全部
取样方法
非概率样本
研究人群
Adults in 14 countries are recruited using the snowballing method.
Data are collected using an online platform (software: Qualtricts).
描述
Inclusion Criteria:
- adults (from general population) who provided informed consent to participate
Exclusion Criteria:
- younger than <18 years old
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
团体/队列数
14
队列和干预
团体/队列团体/队列 |
干预/治疗干预/治疗 |
|---|---|
|
Poland
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Australia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Canada
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
China
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
France
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Gambia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Germany
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Israel
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Italy
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Malaysia
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Portugal
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Romania
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Singapore
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
|
Switzerland
Adults, general population, N = 400
|
Observational data collection only, accounting for COVID-19 morbidity and mortality levels within each country
|
研究衡量的是什么？
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Handwashing adherence
大体时间：1 month
|
The 12-item self-report measure of adherence to handwashing guidelines across situations (e.g., after visiting public spaces, after touching garbage, etc.) based on the guidelines issued by the World Health Organization and the Centers for Disease Control and Prevention.
The responses are provided on a 4-point scale, ranging from 1 (strongly disagree) to 4 (strongly agree).
Higher scores indicate better outcomes (the higher level of adherence to handwashing guidelines).
|
1 month
|
|
Frequency of handwashing
大体时间：1 month
|
The 1-item self-report measure of the frequency of handwashing (for at least 20 seconds, all surfaces of the hands) daily.
The responses are provided on a 4-point scale, ranging from 1 (less than once) to 5 (more than 10 times).
Higher scores indicate better outcomes (the higher frequency of handwashing).
|
1 month
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Self-efficacy
大体时间：1 month
|
4 self-efficacy questionnaire items; mean item score ranging from 1 to 4, higher scores indicate stronger self-efficacy
|
1 month
|
|
Risk perception
大体时间：1 month
|
3 questionnaire items to assess risk perception; mean item score ranging from 1 to 5, higher scores indicate higher risk perception
|
1 month
|
|
Outcome expectancy
大体时间：1 month
|
4 items assessing positive (1 item) and negative (1 items) outcome expectancies; mean item scores ranging from 1 to 4, higher scores indicate more positive outcome expectancies
|
1 month
|
|
Intention
大体时间：1 month
|
2 questionnaire items assessing intention to adhere to handwashing recommendations; mean item scores ranging from 1 to 4, higher scores indicate stronger intention to wash hands (for at least 20 seconds, all surfaces of the hands)
|
1 month
|
|
Planning
大体时间：1 month
|
2 questionnaire items assessing action planning (1 item) and coping planning (1 item); mean item scores ranging from 1 to 4, higher scores indicate a higher level of self-reported planning
|
1 month
|
|
Action control
大体时间：1 month
|
3 questionnaire items assessing a facet of action control, namely self-monitoring; mean item scores ranging from 1 to 4, higher scores indicate a higher level of self-reported monitoring of handwashing behavior
|
1 month
|
|
Perceived effectiveness of hand hygiene
大体时间：1 month
|
1 questionnaire item assessing perceptions of handwashing as an effective means of preventing coronavirus SARS-CoV-2 infection; item scores ranging from 1 to 4, higher scores indicate a higher level of perceived effectiveness of hand hygiene
|
1 month
|
|
Anxiety
大体时间：1 month
|
7-item self-report scale (Generalized Anxiety Disorder, GAD-7) scale to assess anxiety symptoms; mean item scores ranging from 1 to 4, higher scores indicate a higher level of generalized anxiety
|
1 month
|
|
Country-level COVID-19 morbidity and mortality rates
大体时间：60 days
|
The daily cumulative numbers for COVID-19 morbidity and mortality in the study countries.
Published daily as the Situation Report by World Health Organization, starting on 21 January 2020.
Higher numbers indicate the higher cumulative COVID-19 morbidity and mortality rates in the country.
|
60 days
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
调查人员
- 首席研究员：Aleksandra Luszczynska, PhD、SWPS University of Social Sciences and Humanities
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Schwarzer R, Lippke S, Luszczynska A. Mechanisms of health behavior change in persons with chronic illness or disability: the Health Action Process Approach (HAPA). Rehabil Psychol. 2011 Aug;56(3):161-70. doi: 10.1037/a0024509.
- World Health Organization. Coronavirus disease (COVID-19) advice for the public. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
- Centers for Disease Control and Prevention. When and how to wash your hands. 2020. https://www.cdc.gov/handwashing/when-how-handwashing.html
- Reyes Fernandez B, Knoll N, Hamilton K, Schwarzer R. Social-cognitive antecedents of hand washing: Action control bridges the planning-behaviour gap. Psychol Health. 2016 Aug;31(8):993-1004. doi: 10.1080/08870446.2016.1174236. Epub 2016 Apr 26.
- Ruiter RAC, Abraham C, Kok G. Scary warnings and rational precautions: A review of the psychology of fear appeals. Psychol Health. 2011;11(1): 613-630. doi: 10.1080/08870440108405863
- Luszczynska A, Szczuka Z, Abraham C, Baban A, Brooks S, Cipolletta S, Danso E, Dombrowski SU, Gan Y, Gaspar T, de Matos MG, Griva K, Jongenelis MI, Keller J, Knoll N, Ma J, Miah MAA, Morgan K, Peraud W, Quintard B, Shah V, Schenkel K, Scholz U, Schwarzer R, Siwa M, Taut D, Tomaino SCM, Vilchinsky N, Wolf H. The Interplay Between Strictness of Policies and Individuals' Self-Regulatory Efforts: Associations with Handwashing During the COVID-19 Pandemic. Ann Behav Med. 2022 Apr 2;56(4):368-380. doi: 10.1093/abm/kaab102.
- Szczuka Z, Abraham C, Baban A, Brooks S, Cipolletta S, Danso E, Dombrowski SU, Gan Y, Gaspar T, de Matos MG, Griva K, Jongenelis M, Keller J, Knoll N, Ma J, Miah MAA, Morgan K, Peraud W, Quintard B, Shah V, Schenkel K, Scholz U, Schwarzer R, Siwa M, Szymanski K, Taut D, Tomaino SCM, Vilchinsky N, Wolf H, Luszczynska A. The trajectory of COVID-19 pandemic and handwashing adherence: findings from 14 countries. BMC Public Health. 2021 Oct 5;21(1):1791. doi: 10.1186/s12889-021-11822-5.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
学习开始
2020年3月25日
初级完成 (实际的)
初级完成
2020年9月24日
研究完成 (实际的)
研究完成
2020年9月24日
研究注册日期
首次提交
首次提交
2020年4月28日
首先提交符合 QC 标准的
首先提交符合 QC 标准的
2020年4月28日
首次发布 (实际的)
首次发布
2020年4月29日
研究记录更新
最后更新发布 (实际的)
最后更新发布
2021年8月10日
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
2021年8月8日
最后验证
最后验证
2020年8月1日
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- 3228-1BPSYPSBEH-30
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
未定
IPD 计划说明
The lead researchers in 14 countries will have full access to data collected across the countries.
In line with the Consortium Agreement (v2, 16th Jul 2020) data will be openly available under following conditions:
De-identified individual participant data that underline the results reported in publications; individual-level aggregated data (e.g., sum scores for scales) used for main analyses in respective publications; available following the publication, no end date of availability; available for analyses that are conducted to achieve aims in the approved proposal.
Due to local regulations, there are exceptions in terms of data sharing rules (stated above):
- AUSTRALIA: Data from Australia will be available for 5 years after collection.
- GERMANY, SWITZERLAND: Instead of individual-level sum scores, variance-covariance matrices will be shared.
- MALAYSIA: Data will not be shared.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.